Authors


Elizabeth Prechtel-Dunphy

Latest:

Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric Cancer

Shared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.


Jennifer L. Redmond, DrPH

Latest:

Breaking Down the Barriers: Tackling Patient Recruitment Challenges in Clinical Trials

Patients fear being a "guinea pig" or receiving a placebo, healthcare providers do not have time to keep up with all of the clinical trial information or talk with patients in depth, conducting clinical trials is very expensive for healthcare systems, and funding continues to decline for research


Matthew A. Gubens, MD

Latest:

It Takes a Team: Treating Adverse Events

A multidisciplinary care team is needed when treating patients who are given a combination of chemotherapy and immunotherapy.


Terry Arnold

Latest:

Happy Birthday to Me

For myself, one birthday changed the course of my life.


Tami L. Thomas, PhD, CPNP, RNC, FAANP

Latest:

Promoting HPV Vaccination for Girls and Boys

Oncology nurses can lead the way in efforts to protect the next generation from this type of cancer if they know the facts about HPV vaccination for both girls and boys


​Carla Remondini, MSN, RN-BC, AGCNS-BC, OCN

Latest:

Carla Remondini on Language's Effect on A Patient's Ability to Cope

​Carla Remondini, MSN, RN-BC, AGCNS-BC, OCN, of Scripps Mercy Hospital, discuss how language, particularly the use of military metaphors, can affect a patient's ability to cope with cancer.


Lynne Lederman, PhD

Latest:

Reducing Transfusion Burden in Patients With Beta-Thalassemia

A majority of adult patients with β-thalassemia who require regular red blood cell (RBC) transfusions experienced clinically meaningful and durable transfusion burden reduction associated with luspatercept (Reblozyl) in the phase III BELIEVE trial.


Andrew Norden, MD

Latest:

Accessing and Analyzing Clinical Data in EMRs

There is so much important and actionable clinical data found in clinicians' notes in electronic medical records (EMRs).


Jennifer Brown RN, BSN, CPN

Latest:

WHOLElistic Care

I’m sure we can all agree that we’d like to provide the best care possible to our patients each and every day.


Matt Mahady

Latest:

Palliative Care Interventions May Improve Oncology Outcomes

As more studies link aggressive end-of-life oncology care to problems such as suboptimal cost and quality outcomes, experts are increasingly proposing earlier, more comprehensive palliative care interventions.


Canhua Xiao, PhD, RN

Latest:

Canhua Xiao on Managing IMRT-Related Fatigue

Canhua Xiao, PhD, RN, postdoctoral fellow, Nell Hodgson Woodruff School of Nursing, Emory University, discusses ways to manage Intensity-Modulated Radiation Therapy (IMRT)- related fatigue.


Genevieve Ann Hollis, MSN, CRNP, AOCN

Latest:

Penile Rehabilitation in Prostate Cancer Patients

While controversial, advances in understanding how prostate cancer treatments impact the physiology of erections have led to increased interest in penile rehabilitation interventions for these patients.


Karen O. Moss, PhD, RN, CNL

Latest:

Family Caregiver Satisfaction With End-of-Life Care Following Advanced Cancer

Family caregiver satisfaction with end-of-life care is key to better understanding patient experiences.


Karen Lee, MSN, FNP-BC

Latest:

Karen Lee on Explaining Immunotherapy for Patient Education

Karen Lee explains why it is important for patients to understand immunotherapy and how nurses can help them in patients education.


Holly Pederson, MD

Latest:

For Breast Cancer Risk, Density Matters

Dense breast tissue can make tumors more difficult to spot in mammograms. And extremely dense tissue may be an independent risk factor for developing breast cancer.


Roger Lo, MD, PhD

Latest:

Roger Lo on the Evolution of Melanoma During Therapy

Roger Lo, MD, PhD, UCLA Jonsson Comprehensive Cancer Center, discusses the evolution of metastatic melanoma during therapy.


Brian Loew, CEO

Latest:

Brian Loew Explains How Oncology Nurses Can Benefit From Online Patient Communities

Brian Loew, CEO, Inspire, explains how oncology nurses can benefit from online cancer patient communities


Brittany Cote

Latest:

PARP Inhibitor Resistance in Ovarian Cancer: We Need More Trials

While PARP inhibitors have played a large part in improving progression-free survival (PFS) in patients with ovarian cancer, long-term use of these agents often leads to resistance that are often quite challenging to overcome, according to Gottfried E. Konecny, MD.


Nancy Corbitt, BSN, RN, OCN, CRNI

Latest:

MDS Treatment Takes a Team

There are multiple key players, including oncology nurses, in the treatment of patients with myelodysplastic syndrome.


ANNMARIE PAPIK, BS

Latest:

Caregivers' Mental Health Varies by Gender

Even with the rise in male caregivers for patients with cancer, little research has been done to ensure there is effective support for both male and female caregivers. Several researchers have reported that men experience fewer negative aspects of caregiving (such as depression) compared with female caregivers.


Karen Ayers, ACHPN

Latest:

Innovative Use of Technology for Palliative Care

Innovative models for palliative care delivery and primary palliative care training are springing up to address the mismatch between the demand for this care and the capacity to deliver it.


Karley Trautman, DNP, ANP-BC

Latest:

Karley Trautman on Decreasing Venous Thromboembolism in Patients with Blood Cancers

Karley Trautman, DNP, ANP-BC, of University of Colorado Hospital explains how a quality improvement program helped them to reduce venous thromboembolism (VTE).



Melissa L. Bondy,

Latest:

Melissa L. Bondy on the Importance of Finding Glioma-Causing Genes

Melissa L. Bondy, PhD, MS, associate director for cancer prevention and population sciences at Baylor College of Medicine, discusses the importance of finding genetic mutations that can cause cancers such as glioma.


Patrick W. Whitworth, MD

Latest:

Bioimpedance Spectroscopy Can Help Prevent Clinical Lymphedema

Several breast cancer treatment programs are reporting substantially less clinical lymphedema, particularly among patients at high risk after axillary dissection, radiation, or taxane-based chemotherapy, crediting their use of preclinical detection using bioimpedance spectroscopy (BIS).


Rebecca Lehto, PhD, RN, OCN

Latest:

Rebecca Lehto Discusses Holistic Treatment

Rebecca Lehto, PhD, RN, OCN, assistant professor, College of Nursing, Michigan State University, discusses holistically treating patients with cancer.


Elaine S. DeMeyer RN, MSN, AOCN

Latest:

Is It OK for an Oncology Nurse to Attend a Patient's Funeral?

Consider the family's feelings and check workplace policies when determining how best to share condolences and cope with your grief.


Michelle Gervino, RN, BSN, OCN

Latest:

Michelle Gervino Discusses Side Effect Management in Patients with Hematologic Malignancies

Michelle Gervino, RN, BSN, OCN, John Theurer Cancer Center, discusses side effects that patients with hematologic malignancies may experience during treatment


Sharon L. Bober, PhD

Latest:

Sharon L. Bober, PhD, Discusses Sexual Health Changes in Relation to Treatment

Sharon L. Bober, PhD, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses how changes in sexual health differ with various treatments.


Grace Cherry, NP, MSN, RN

Latest:

More for Melanoma: Nurse Discusses Unmet Needs

Despite many exciting advances in recent years, there are still aspects of melanoma treatment that need to be further studied and understood, said Grace Cherry, NP, a nurse practitioner at UCLA Health.

© 2024 MJH Life Sciences

All rights reserved.